These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Development and In Vivo Application of a Water-Soluble Anticancer Copper Ionophore System Using a Temperature-Sensitive Liposome Formulation. Gaál A; Garay TM; Horváth I; Máthé D; Szöllősi D; Veres DS; Mbuotidem J; Kovács T; Tóvári J; Bergmann R; Streli C; Szakács G; Mihály J; Varga Z; Szoboszlai N Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32443790 [TBL] [Abstract][Full Text] [Related]
51. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes. Stevens PJ; Lee RJ Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245 [TBL] [Abstract][Full Text] [Related]
52. The ionophore nigericin transports Pb2+ with high activity and selectivity: a comparison to monensin and ionomycin. Hamidinia SA; Tan B; Erdahl WL; Chapman CJ; Taylor RW; Pfeiffer DR Biochemistry; 2004 Dec; 43(50):15956-65. PubMed ID: 15595852 [TBL] [Abstract][Full Text] [Related]
53. Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein. Manojlovic V; Winkler K; Bunjes V; Neub A; Schubert R; Bugarski B; Leneweit G Colloids Surf B Biointerfaces; 2008 Jul; 64(2):284-96. PubMed ID: 18359207 [TBL] [Abstract][Full Text] [Related]
54. Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity. Semple SC; Leone R; Wang J; Leng EC; Klimuk SK; Eisenhardt ML; Yuan ZN; Edwards K; Maurer N; Hope MJ; Cullis PR; Ahkong QF J Pharm Sci; 2005 May; 94(5):1024-38. PubMed ID: 15793796 [TBL] [Abstract][Full Text] [Related]
55. Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform. Saraf S; Jain A; Hurkat P; Jain SK Crit Rev Ther Drug Carrier Syst; 2016; 33(5):401-432. PubMed ID: 27910741 [TBL] [Abstract][Full Text] [Related]
56. Ion-Pairing Contribution to the Liposomal Transport of Topotecan as Revealed by Mechanistic Modeling. Fugit KD; Anderson BD J Pharm Sci; 2017 Apr; 106(4):1149-1161. PubMed ID: 28007561 [TBL] [Abstract][Full Text] [Related]
57. In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan. Hao YL; Deng YJ; Chen Y; Wang KZ; Hao AJ; Zhang Y J Pharm Pharmacol; 2005 Oct; 57(10):1279-87. PubMed ID: 16259756 [TBL] [Abstract][Full Text] [Related]